Commensal Clostridia: leading players in the maintenance of gut homeostasisLoris Riccardo Lopetuso, Antonio Gasbarrini|Gut Pathogens|2013Cited by 753
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 studyArmando Santoro, Camillo Porta, Lorenza Rimassa et al.|The Lancet Oncology|2012Cited by 550
Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamicsMauro Bernardi, Giovanni Gasbarrini, Lorenzo Fornalé et al.|Journal of Hepatology|1995Cited by 98
Hepatorenal Disorders: Role of the Renin-Angiotensin-Aldosterone SystemMauro Bernardi, Giovanni Gasbarrini, Franco Trevisani et al.|Seminars in Liver Disease|1994Cited by 90
Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative studyFabio Caputo, Mauro Bernardi, Giovanni Addolorato et al.|Drug and Alcohol Dependence|2003Cited by 76